SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Bardwell Kathleen

(Last) (First) (Middle)
5960 HEISLEY ROAD

(Street)
MENTOR OH 44060

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
02/21/2014
3. Issuer Name and Ticker or Trading Symbol
STERIS CORP [ STE ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Sr.V. P. & C.C.O.
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares, No Par Value 12,679(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Option to Purchase Common Shares (2) 05/21/2019 Common Shares, No Par Value 962 22.83 D
Option to Purchase Common Shares (3) 11/12/2019 Common Shares, No Par Value 1,000 34.23 D
Option to Purchase Common Shares (4) 05/20/2020 Common Shares, No Par Value 4,275 31.87 D
Option to Purchase Common Shares (5) 05/31/2021 Common Shares, No Par Value 4,000 36.09 D
Option to Purchase Common Shares (6) 05/30/2022 Common Shares, No Par Value 3,795 29.94 D
Option to Purchase Common Shares (7) 05/31/2023 Common Shares, No Par Value 5,360 45.34 D
Explanation of Responses:
1. 8,840 of these Common Shares are restricted. The restrictions on these Common Shares lapse as follows: 1,575 on May 20, 2014; 1,155 on May 30, 2014; 450 on June 2, 2014; 1,000 on June 2, 2014; 450 on June 1, 2015; 1,000 on June 1, 2015; 1,155 on June 1, 2015; 450 on May 31, 2016; 1,155 on May 31, 2016 and 450 on May 31, 2017.
2. These options became exercisable as follows: 962 on May 21, 2013.
3. These options became exercisable as follows: 250 on November 12, 2010; 250 on November 12, 2011; 250 on November 12, 2012 and 250 on November 12, 2013.
4. These options became or will become exercisable as follows: 1,069 on May 20, 2011; 1,069 on May 20, 2012; 1,069 on May 20, 2013 and 1,068 on May 20, 2014.
5. These options became or will become exercisable as follows: 1,000 on May 31, 2012; 1,000 on May 31, 2013; 1,000 on May 31, 2014 and 1,000 on May 31, 2015.
6. These options became or will become exercisable as follows: 948 on May 30, 2013; 948 on May 30, 2014; 948 on May 30, 2015 and 949 on May 30, 2016.
7. These options become exercisable as follows: 1,340 on May 31, 2014; 1,340 on May 31, 2015; 1,340 on May 31, 2016 and 1,340 on May 31, 2017.
Remarks:
Exhibit 24-Power of Attorney is attached.
/s/ Dennis P. Patton, Authorized Representative under Power of Attorney 02/27/2014
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
rrd363675_411986.html
Securities and Exchange Commission
Washington, D.C. 20549

RE:      STERIS Corporation

Commission File No. 0-20165
1933 Act and 1934 Act Filings
Authorized Representatives

Gentlemen:

      The above Company is the issuer of securities registered under Section 12 of
the Securities Exchange Act of 1934. The person signing below confirms, as of the date appearing
opposite his/her signature, that each of the "Authorized Representatives" named below is
authorized on his/her behalf to sign such statements (on Form 3, Form 4, Form 5, Form 144,
Schedule 13G, or otherwise) with respect to securities of the Company (the "Securities"), and to
submit to the Securities and Exchange Commission such filings (including reports, notices, and
other statements) with respect to the Securities, as are required by the Securities Act of 1933, as
amended, or the Securities Exchange Act of 1934 as amended (collectively, the "Acts"). The
person so signing also confirms the authority of each of the Authorized Representatives to do and
perform, on his/her behalf, any and all acts and things with respect to the Securities requisite or
necessary to assure compliance by the signing person with the filing requirements of the Acts. This
authority revokes all prior authorities with respect to the Securities previously executed by the
person signing below including but not limited to any such authorities filed with or given to the
Commission by the person signing below. The authority confirmed herein shall remain in effect as
to the person signing below until such time as the Commission shall receive from that person a
written communication that terminates or modifies the authority.

Authorized Representatives
Judith A. Hunter
Dennis P. Patton
Ronald E. Snyder
Michael J. Tokich
J. Adam Zangerle


Dated: 2/20/2014					By: /s/ Kathleen L. Bardwell
							Printed Name:  Kathleen L. Bardwell


Shareholder Tools